BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 24932569)

  • 1. WWOX at the crossroads of cancer, metabolic syndrome related traits and CNS pathologies.
    Aldaz CM; Ferguson BW; Abba MC
    Biochim Biophys Acta; 2014 Aug; 1846(1):188-200. PubMed ID: 24932569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cancer gene WWOX behaves as an inhibitor of SMAD3 transcriptional activity via direct binding.
    Ferguson BW; Gao X; Zelazowski MJ; Lee J; Jeter CR; Abba MC; Aldaz CM
    BMC Cancer; 2013 Dec; 13():593. PubMed ID: 24330518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WWOX: a fragile tumor suppressor.
    Schrock MS; Huebner K
    Exp Biol Med (Maywood); 2015 Mar; 240(3):296-304. PubMed ID: 25538133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common Chromosomal Fragile Site Gene WWOX in Metabolic Disorders and Tumors.
    Li J; Liu J; Ren Y; Yang J; Liu P
    Int J Biol Sci; 2014; 10(2):142-8. PubMed ID: 24520212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the WWOX gene, encompassing fragile region FRA16D, in suppression of pancreatic carcinoma cells.
    Nakayama S; Semba S; Maeda N; Aqeilan RI; Huebner K; Yokozaki H
    Cancer Sci; 2008 Jul; 99(7):1370-6. PubMed ID: 18460020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of the WWOX in pathogenesis and endocrine therapy of breast cancer.
    Li J; Liu J; Ren Y; Liu P
    Exp Biol Med (Maywood); 2015 Mar; 240(3):324-8. PubMed ID: 25476151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WWOX, the common fragile site FRA16D gene product, regulates ATM activation and the DNA damage response.
    Abu-Odeh M; Salah Z; Herbel C; Hofmann TG; Aqeilan RI
    Proc Natl Acad Sci U S A; 2014 Nov; 111(44):E4716-25. PubMed ID: 25331887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WWOX P47T partial loss-of-function mutation induces epilepsy, progressive neuroinflammation, and cerebellar degeneration in mice phenocopying human SCAR12.
    Hussain T; Sanchez K; Crayton J; Saha D; Jeter C; Lu Y; Abba M; Seo R; Noebels JL; Fonken L; Aldaz CM
    Prog Neurobiol; 2023 Apr; 223():102425. PubMed ID: 36828035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decoding the link between WWOX and p53 in aggressive breast cancer.
    Abdeen SK; Aqeilan RI
    Cell Cycle; 2019 Jun; 18(11):1177-1186. PubMed ID: 31075076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of compound heterozygous deletion of the WWOX gene in WOREE syndrome.
    Dong XS; Wen XJ; Zhang S; Wang DG; Xiong Y; Li ZM
    BMC Med Genomics; 2023 Nov; 16(1):291. PubMed ID: 37974179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal neuronal WWOX gene therapy rescues Wwox null phenotypes.
    Repudi S; Kustanovich I; Abu-Swai S; Stern S; Aqeilan RI
    EMBO Mol Med; 2021 Dec; 13(12):e14599. PubMed ID: 34747138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel whole exon deletion in WWOX gene causes early epilepsy, intellectual disability and optic atrophy.
    Ben-Salem S; Al-Shamsi AM; John A; Ali BR; Al-Gazali L
    J Mol Neurosci; 2015 May; 56(1):17-23. PubMed ID: 25403906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WWOX-related encephalopathies: delineation of the phenotypical spectrum and emerging genotype-phenotype correlation.
    Mignot C; Lambert L; Pasquier L; Bienvenu T; Delahaye-Duriez A; Keren B; Lefranc J; Saunier A; Allou L; Roth V; Valduga M; Moustaïne A; Auvin S; Barrey C; Chantot-Bastaraud S; Lebrun N; Moutard ML; Nougues MC; Vermersch AI; Héron B; Pipiras E; Héron D; Olivier-Faivre L; Guéant JL; Jonveaux P; Philippe C
    J Med Genet; 2015 Jan; 52(1):61-70. PubMed ID: 25411445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The common fragile site FRA16D gene product WWOX: roles in tumor suppression and genomic stability.
    Aqeilan RI; Abu-Remaileh M; Abu-Odeh M
    Cell Mol Life Sci; 2014 Dec; 71(23):4589-99. PubMed ID: 25245215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delineating WWOX Protein Interactome by Tandem Affinity Purification-Mass Spectrometry: Identification of Top Interactors and Key Metabolic Pathways Involved.
    Hussain T; Lee J; Abba MC; Chen J; Aldaz CM
    Front Oncol; 2018; 8():591. PubMed ID: 30619736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-Wide Association Study of Liver Fat: The Multiethnic Cohort Adiposity Phenotype Study.
    Park SL; Li Y; Sheng X; Hom V; Xia L; Zhao K; Pooler L; Setiawan VW; Lim U; Monroe KR; Wilkens LR; Kristal BS; Lampe JW; Hullar M; Shepherd J; Loo LLM; Ernst T; Franke AA; Tiirikainen M; Haiman CA; Stram DO; Le Marchand L; Cheng I
    Hepatol Commun; 2020 Aug; 4(8):1112-1123. PubMed ID: 32766472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GIV/Girdin is a central hub for profibrogenic signalling networks during liver fibrosis.
    Lopez-Sanchez I; Dunkel Y; Roh YS; Mittal Y; De Minicis S; Muranyi A; Singh S; Shanmugam K; Aroonsakool N; Murray F; Ho SB; Seki E; Brenner DA; Ghosh P
    Nat Commun; 2014 Jul; 5():4451. PubMed ID: 25043713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroimaging features of WOREE syndrome: a mini-review of the literature.
    Battaglia L; Scorrano G; Spiaggia R; Basile A; Palmucci S; Foti PV; Spatola C; Iacomino M; Marinangeli F; Francia E; Comisi F; Corsello A; Salpietro V; Vittori A; David E
    Front Pediatr; 2023; 11():1301166. PubMed ID: 38161429
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.